Project documents | Pembrolizumab for previously treated oesophageal or gastro-oesophageal junction cancer [ID1357] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final stakeholder list (PDF 212 KB)

Published:

07 March 2019
Final scope (PDF 297 KB)

Published:

07 March 2019
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 125 KB)

Published:

07 March 2019
Equality Impact Assessment (Guidance development) (PDF 125 KB)

Published:

07 March 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 450 KB)

Published:

11 April 2018
Draft matrix post referral (PDF 341 KB)

Published:

11 April 2018